Aptabio Therapeutics Inc. — Investor Relations & Filings
Aptabio Therapeutics Inc. is a biopharmaceutical company dedicated to developing first-in-class drugs for intractable diseases with high unmet medical needs. The company's research is driven by proprietary platform technologies. One core platform focuses on regulating oxidative stress through selective NOX (NADPH oxidase) inhibitors, targeting the root causes of inflammation and fibrosis to treat diabetic complications, vascular diseases, and neurodegenerative disorders. A second platform centers on the regulation of cancer-associated fibroblasts (CAF) to overcome resistance and enhance the efficacy of immuno-oncology therapies for difficult-to-treat cancers. By leveraging these distinct approaches, Aptabio aims to discover and advance novel therapeutic candidates for challenging medical conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2023.03) | 2023-05-15 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-05-08 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-05-08 | Korean | |
| 투자판단관련주요경영사항(임상시험계획승인신청등결정)(조영제유발급성신장손상(CI-AKI) 치료제 Isuzinaxib(APX-115)의 국내 2상 임상시험 계획(IND) 승인) | 2023-05-02 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-04-24 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-04-24 | Korean |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 8338233 | 분기보고서 (2023.03) | 2023-05-15 | Korean | ||
| 8346133 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-05-08 | Korean | ||
| 8346131 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-05-08 | Korean | ||
| 8347448 | 투자판단관련주요경영사항(임상시험계획승인신청등결정)(조영제유발급성신장손상(CI-AKI) 치료제 Isuzinaxib(APX-115)의 국내 2상 임상시험 계획(IND) 승인) | 2023-05-02 | Korean | ||
| 8351109 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-04-24 | Korean | ||
| 8351108 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-04-24 | Korean | ||
| 8361453 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-04-03 | Korean | ||
| 8361422 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-04-03 | Korean | ||
| 8364290 | 정기주주총회결과 | 2023-03-30 | Korean | ||
| 8369104 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-03-27 | Korean | ||
| 8369078 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-03-27 | Korean | ||
| 8376439 | 감사보고서제출 | 2023-03-22 | Korean | ||
| 8376411 | 사업보고서 (2022.12) | 2023-03-22 | Korean | ||
| 8383672 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-03-20 | Korean | ||
| 8383601 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2023-03-20 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Aptabio Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15754/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15754 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15754 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15754 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15754}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aptabio Therapeutics Inc. (id: 15754)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.